Singapore in the International Regulatory Landscape
Singapore as a regulatory hub
Singapore occupies a distinctive position in the global medical device regulatory landscape. It is simultaneously:
- A founding member and active participant of the International Medical Device Regulators Forum (IMDRF);
- A leading voice in ASEAN medical device harmonisation through the ASEAN Medical Device Committee (AMDC);
- A jurisdiction that formally recognises approvals from the world's five major reference agencies (TGA, EU NB, Health Canada, MHLW, FDA) as the basis for streamlined registration.
This combination makes Singapore both a strategically important market in its own right and a gateway to the broader Southeast Asian region.
Why Singapore matters for market access strategy
For overseas manufacturers, Singapore's regulatory reliance framework means that existing approvals from major reference jurisdictions — particularly combinations of CE marking + TGA, or FDA + Health Canada — can significantly accelerate Singapore registration via the Abridged, Expedited, or Immediate routes.
Singapore registration, in turn, is recognised or accepted as part of national regulatory submissions in multiple ASEAN countries, and a Singapore Free Sale Certificate is commonly required for ASEAN market entry applications.
The sections in this part of RAPath SG
| Page | What it covers |
|---|---|
| Regulatory Reliance | What regulatory reliance means in Singapore's context, and how it works in practice |
| IMDRF | Singapore's IMDRF membership and how IMDRF guidance shapes Singapore requirements |
| ASEAN AMDC | The ASEAN Medical Device Committee and the ASEAN harmonisation framework |
| ASEAN CSDT | The ASEAN Common Submission Dossier Template and its use in regional submissions |
| SG vs other jurisdictions | Comparison of Singapore's framework with TGA, FDA, CE marking, and Health Canada |